• 3239 Citations
  • 31 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Multiple Myeloma Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences
Survival Medicine & Life Sciences
Chromosome Aberrations Medicine & Life Sciences
Griseofulvin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

9 Citations (Scopus)

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Walker, B. A., Mavrommatis, K., Wardell, C. P., Ashby, T. C., Bauer, M., Davies, F., Rosenthal, A., Wang, H., Qu, P., Hoering, A., Samur, M., Towfic, F., Ortiz, M., Flynt, E., Yu, Z., Yang, Z., Rozelle, D., Obenauer, J., Trotter, M., Auclair, D. & 19 othersKeats, J., Bolli, N., Fulciniti, M., Szalat, R., Moreau, P., Durie, B., Stewart, A. K., Goldschmidt, H., Raab, M-S., Einsele, H., Sonneveld, P., San Miguel, J., Lonial, S., Jackson, G. H., Anderson, K. C., Avet-Loiseau, H., Munshi, N., Thakurta, A. & Morgan, G., Jan 1 2019, In : Leukemia. 33, 1, p. 159-170 12 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Multiple Myeloma
Survival
Genome
Exome

Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

for the German-speaking Myeloma Multicenter Group (GMMG), Jan 1 2019, In : Leukemia. 33, 1, p. 258-261 4 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Transplants
Therapeutics
Bortezomib

Erratum zu: Primärtherapie beim Multiplen Myelom (Der Internist, (2019), 60, 1, (23-33), 10.1007/s00108-018-0527-x)

Breitkreutz, I., Raab, M-S. & Goldschmidt, H., Jan 1 2019, In : Internist.

Research output: Contribution to journalComment/debate

Open Access
Multiple Myeloma

Primärtherapie beim Multiplen Myelom

Breitkreutz, I., Raab, M-S. & Goldschmidt, H., Jan 1 2019, In : Internist. 60, 1, p. 23-33 11 p.

Research output: Contribution to journalReview article

Multiple Myeloma
Stem Cell Transplantation
Melphalan
Dexamethasone
Therapeutics
3 Citations (Scopus)

Spectrum and functional validation of PSMB5 mutations in multiple myeloma

Barrio, S., Stühmer, T., Da-Viá, M., Barrio-Garcia, C., Lehners, N., Besse, A., Cuenca, I., Garitano-Trojaola, A., Fink, S., Leich, E., Chatterjee, M., Driessen, C., Martinez-Lopez, J., Rosenwald, A., Beckmann, R., Bargou, R. C., Braggio, E., Stewart, A. K., Raab, M-S., Einsele, H. & 1 othersKortüm, K. M., Feb 1 2019, In : Leukemia. 33, 2, p. 447-456 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Proteasome Inhibitors
Mutation
Proteasome Endopeptidase Complex
Clonal Evolution